Vote Scores
Filings read through

How funds voted at Cerevel Therapeutics Holdings, Inc.

Filers reporting
296, year to 30 June 2024
Latest meeting on file
Meetings on file
1

In the year to 30 June 2024, 296 filers on Form N-PX reported votes at Cerevel Therapeutics Holdings, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 481 marks to the ballot items, each with or against management. 52.4% of the marks are with management.

On say-on-pay, 212 of the 273 reporting filers that marked the item voted against management. This is 77.7% of the filers. Of the reported shares, 99.3% went against management. The median of the 3,781 companies on this site with a say-on-pay item is 7.5% of filers and 2.9% of reported shares.

At the meeting of 16 Feb 2024, 6 fund families have a say-on-pay position with management and 34 have a position against management.

By filers reporting in the year to 30 June 2024, Cerevel Therapeutics Holdings, Inc. was number 1,865 of 11,775 companies with a page and votes in that year. In all seasons on file, category DIRECTOR ELECTIONS is 0.0% of the vote records at Cerevel Therapeutics Holdings, Inc.. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 16 Feb 2024

295 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    409 vote records from 287 filers. 212 of the 273 filers that marked the item voted against management. 14 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 40 fund families
    • For 6
    • Against 33
    • Abstain or withhold 1
    • Against management 34
  2. Item 2: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    161 vote records from 95 filers. 0 of the 95 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 32
  3. Item 3: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    210 vote records from 113 filers. 17 of the 113 filers that marked the item voted against management.

    • Positions of 36 fund families
    • For 30
    • Against 6
    • Against management 6

Positions of the fund families at the meeting of 16 Feb 2024

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Cerevel Therapeutics Holdings, Inc., meeting of 16 Feb 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
AllianceBernsteinAgainst, against management
American CenturyAgainst, against management
BlackRock and iSharesAgainst, against management
BNY MellonAgainst, against management
Brighthouse FundsAgainst, against management
Capital Group and American FundsAgainst, against management
Charles SchwabAgainst, against management
Columbia ThreadneedleAgainst, against management
DimensionalAgainst, against management
DWSAgainst, against management
EquitableAgainst, against management
FidelityAgainst, against management
Global XAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
Harbor FundsFor
InvescoAgainst, against management
J.P. MorganAgainst, against management
Jackson National fundsAgainst, against management
Janus HendersonAgainst, against management
John Hancock and ManulifeAgainst, against management
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
NationwideAgainst, against management
Neuberger BermanFor
Northern Trust and FlexSharesAgainst, against management
Nuveen and TIAAAgainst, against management
Pacific Life fundsAgainst, against management
PGIM and PrudentialFor
PIMCOAgainst, against management
PrincipalAgainst, against management
ProShares and ProFundsAgainst, against management
SEIAgainst, against management
State Street and SPDRFor
T. Rowe PriceAgainst, against management
TransamericaAgainst, against management
VanguardAgainst, against management
Victory CapitalAgainst, against management
VirtusFor
VoyaAbstain, against management

Every meeting on file

Meetings of Cerevel Therapeutics Holdings, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2024295377.7%

Say-on-pay, season by season

Say-on-pay at Cerevel Therapeutics Holdings, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202429677.7%99.3%
Cerevel Therapeutics Holdings, Inc. and the median of companies on this site, year to 30 June 2024
Say-on-payThis companyMedian of companies on this site
Filers against management77.7%7.5%
Reported shares against management99.3%2.9%

The median covers 3,781 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Cerevel Therapeutics Holdings, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
SECTION 14A SAY-ON-PAY VOTES40952.4%
EXTRAORDINARY TRANSACTIONS16120.6%
CORPORATE GOVERNANCE21026.9%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Cerevel Therapeutics Holdings, Inc.. https://votescores.com/company/cerevel-therapeutics-holdings-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Cerevel Therapeutics Holdings, Inc. are on file?
1 meeting is on file, on 16 Feb 2024. 1 meeting has 20 or more reporting filers and has its own page.
Did filers report proposals from security holders at Cerevel Therapeutics Holdings, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2024. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Cerevel Therapeutics Holdings, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Cerevel Therapeutics Holdings, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .